3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells

Jonathan R. Dimmock, Umashankar Das, H. Inci Gul, Masami Kawase, Hiroshi Sakagami, Zoltán Baráth, Imre Ocsovsky, J. Molnár

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The incorporation of the 1-aryl-5-(4-nitrophenyl)-3-oxo-1,4-pentadienyl group into 3,4-dihydro-1H-naphthalenyl, cyclohexyl, 2,3-dihydro-1H-indenyl and cyclopentyl scaffolds led to the discovery of various compounds with selective toxicity for malignant cells and ability to reverse multidrug resistance.

Original languageEnglish
Pages (from-to)1633-1636
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number6
DOIs
Publication statusPublished - Mar 15 2005

Fingerprint

Multiple Drug Resistance
Scaffolds
Toxicity
4-nitrophenyl

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells. / Dimmock, Jonathan R.; Das, Umashankar; Gul, H. Inci; Kawase, Masami; Sakagami, Hiroshi; Baráth, Zoltán; Ocsovsky, Imre; Molnár, J.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 15, No. 6, 15.03.2005, p. 1633-1636.

Research output: Contribution to journalArticle

Dimmock, Jonathan R. ; Das, Umashankar ; Gul, H. Inci ; Kawase, Masami ; Sakagami, Hiroshi ; Baráth, Zoltán ; Ocsovsky, Imre ; Molnár, J. / 3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells. In: Bioorganic and Medicinal Chemistry Letters. 2005 ; Vol. 15, No. 6. pp. 1633-1636.
@article{5d1abebced66490db527e23919871445,
title = "3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells",
abstract = "The incorporation of the 1-aryl-5-(4-nitrophenyl)-3-oxo-1,4-pentadienyl group into 3,4-dihydro-1H-naphthalenyl, cyclohexyl, 2,3-dihydro-1H-indenyl and cyclopentyl scaffolds led to the discovery of various compounds with selective toxicity for malignant cells and ability to reverse multidrug resistance.",
author = "Dimmock, {Jonathan R.} and Umashankar Das and Gul, {H. Inci} and Masami Kawase and Hiroshi Sakagami and Zolt{\'a}n Bar{\'a}th and Imre Ocsovsky and J. Moln{\'a}r",
year = "2005",
month = "3",
day = "15",
doi = "10.1016/j.bmcl.2005.01.054",
language = "English",
volume = "15",
pages = "1633--1636",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - 3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells

AU - Dimmock, Jonathan R.

AU - Das, Umashankar

AU - Gul, H. Inci

AU - Kawase, Masami

AU - Sakagami, Hiroshi

AU - Baráth, Zoltán

AU - Ocsovsky, Imre

AU - Molnár, J.

PY - 2005/3/15

Y1 - 2005/3/15

N2 - The incorporation of the 1-aryl-5-(4-nitrophenyl)-3-oxo-1,4-pentadienyl group into 3,4-dihydro-1H-naphthalenyl, cyclohexyl, 2,3-dihydro-1H-indenyl and cyclopentyl scaffolds led to the discovery of various compounds with selective toxicity for malignant cells and ability to reverse multidrug resistance.

AB - The incorporation of the 1-aryl-5-(4-nitrophenyl)-3-oxo-1,4-pentadienyl group into 3,4-dihydro-1H-naphthalenyl, cyclohexyl, 2,3-dihydro-1H-indenyl and cyclopentyl scaffolds led to the discovery of various compounds with selective toxicity for malignant cells and ability to reverse multidrug resistance.

UR - http://www.scopus.com/inward/record.url?scp=14644408660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644408660&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2005.01.054

DO - 10.1016/j.bmcl.2005.01.054

M3 - Article

VL - 15

SP - 1633

EP - 1636

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 6

ER -